SCHEMBL20982037

SCHEMBL20982037

CCO[Si](CCCN(Cc1ccco1)C(=S)S)(OCC)OCC

nearest known ligand 0.40

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ POLB P06746 3/20 0.40
▸ TRPM8 Q7Z2W7 1/20 0.39
▸ L3MBTL1 Q9Y468 4/20 0.39
▸ LMNA P02545 1/20 0.39
▸ ALDH1A1 P00352 3/20 0.39
▸ GAA P10253 2/20 0.39
▸ KMT2A Q03164 1/20 0.38
▸ MAPT P10636 4/20 0.38
▸ CYP1A2 P05177 2/20 0.38
▸ CYP3A4 P08684 2/20 0.38
▸ CYP2D6 P10635 2/20 0.38
▸ CYP2C9 P11712 2/20 0.38
▸ CYP2C19 P33261 2/20 0.38
▸ NPSR1 Q6W5P4 2/20 0.38
▸ ALOX12 P18054 1/20 0.38
▸ TDP1 Q9NUW8 1/20 0.37
▸ SMN1; SMN2 Q16637 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20982035 0.84 POLB (0.36) POLBTRPM8L3MBTL1LMNAALDH1A1
SCHEMBL20982048 0.82 HTT (0.46) POLBLMNAALDH1A1GAAKMT2A
SCHEMBL20982032 0.80 POLB (0.41) POLBTRPM8ALDH1A1GAAMAPT
SCHEMBL9353548 0.77 ABCB11 (0.40) ALDH1A1
SCHEMBL20982064 0.76 ALDH1A1 (0.46) POLBL3MBTL1LMNAALDH1A1GAA
SCHEMBL20982062 0.74 POLB (0.34) POLBTRPM8L3MBTL1LMNAALDH1A1
SCHEMBL25370911 0.73 ALDH1A1 (0.42) POLBL3MBTL1ALDH1A1MAPTCYP1A2
SCHEMBL14974065 0.72 TSHR (0.44) POLBALDH1A1MAPTNPSR1
SCHEMBL14974204 0.71 TP53 (0.43) POLBALDH1A1KMT2AMAPTNPSR1
SCHEMBL14973686 0.71 ALDH1A1 (0.39) POLBALDH1A1MAPTNPSR1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10913805-B2 Modifier, method for preparing the same, and modified conjugated diene-based polymer including the same LG CHEM, LTD. 2021-02-09 — — US disclosed
EP-3486279-B1 MODIFIER, METHOD FOR PREPARING SAME, AND MODIFIED CONJUGATED DIENE-BASED POLYMER COMPRISING SAME LG CHEMICAL LTD (KR) 2020-09-09 — — EP disclosed
US-20190177457-A1 Modifier, Method For Preparing The Same, And Modified Conjugated Diene-Based Polymer Including The Same LG CHEM, LTD. (KR) 2019-06-13 — — US disclosed
EP-3486279-A1 MODIFIER, METHOD FOR PREPARING SAME, AND MODIFIED CONJUGATED DIENE-BASED POLYMER COMPRISING SAME LG Chem, Ltd. (KR) 2019-05-22 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190177457-A1 Modifier, Method For Preparing The Same, And Modified Conjugated Diene-Based Polymer Including The Same FDFT1, DHPS, ALOX5 POLB 2231/4885TRPM8 4198/4885L3MBTL1 4674/4885
US-10913805-B2 Modifier, method for preparing the same, and modified conjugated diene-based polymer including the same FDFT1, DHPS, ALOX5 POLB 2231/4885TRPM8 4198/4885L3MBTL1 4674/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback